Retrospective Study of Traditional Chinese Medicine Treatment on Diabetes Mellitus

来源 :世界中医药学会联合会方药量效研究专业委员会成立大会暨第二届国际方药量效关系与合理应用研讨会 | 被引量 : 0次 | 上传用户:a391137182
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Introduction: Diabetes mellitus (DM) is complex disorder characterized by chronic hyperglycemia, the epidemic growth in obesity and elderly population contribute to the prevalence of DM.Traditional Chinese medicine (TCM) has a long history of treatment for DM.Professor Tong Xiao-Lin is an expert in the use of TCM for treatingDM in China,he mentioned the method of "clear away the heat anddirect the turbid downward", which directed preparations that aimed to improve the syndrome,subjective symptoms, and chemical indicators to treat DM.Dahuang Huanglian Xiexin Decoction (DHXD) is a commonly used formula in his clinical practice.Objective:The study aims toprovide clinical evidence in support of DHXDtotreat DM andto introduce a new treatment option for clinicians.Methods:The method of retrospective analysis was applied.Based on Professor Tongs clinic medical records, diabetic patients who met the inclusion criteria and who were seen in the clinic between January 1, 2013 and January 1, 2014 were enrolled in this study.General information (name, sex and age, etc.), symptoms, blood glucose levels and blood lipid levels were recorded and collected, followed by standardized process.The effects of the treatment were evaluated by the changes in FBG,PBG,HbA 1 C, blood lipid series and BMI between the baseline levels and the post-treatment levels at 1-, 2-, 3-or 6-months, the changes in main symptoms were also evaluated.Statistical software SPSS 17.0 wasused to analyze and process the standardized data.Results:One hundred and eighty-three patients with 678 clinical visits were included in this retrospective study.There was a significant improvement in HbA1C at every return visit compared with the baseline level.Mean HbA1C was 7.98±1.7% at 0 month,7.83±1.48% at 1 month, 7.69±1.05% at 2 months,7.12±1.15% at 3 months (p<0.01)and 6.84±1.09% at 6 months(p<0.01).There were also significant improvements in FBG,PBG, blood lipid seriesandBMI.DHXD had effects on reducing the scores of main symptoms and alleviating main symptoms.Conclusions:Preliminary evidence from thisstudy suggests that DHXD could decrease FBG, PBG and HbA1C of diabetic patients, reducing the body weight,correcting disorders of lipid metabolism, and improving diabetic symptoms, the use of DHXDto treat DM may be a new treatment option.Prospective studies are required to provide stronger evidence in future researches.
其他文献
会议
目的:采用代谢物组整体效应,考察不同剂量大承气汤对不完全性肠梗阻大鼠模型大鼠治疗作用的量效关系.方法:血浆预处理以后,UHPLC/Q-TOF采集血浆样品数据,建立数据矩阵,使用PCA等化学计量学的方法分析数据矩阵,提取能够反映病症与疗效的代谢物组,考察代谢物组随剂量的变化趋势,以代谢物组的大承气汤整方的量效关系.结果:在主成分得分图中,剂量组随着剂量的增大,其样本点逐渐远离模型组向空白组回归;以剂
建立同时测定天麻素及其代谢产物天麻苷元、葛根素和内标对羟基苯乙醇(Tyr)4种成分在大鼠血浆中药物浓度的HPLC方法,并应用该法研究单独或合并静脉注射及灌胃给药天麻素、葛根素后,三者在大鼠体内药代动力学过程及相互影响.以Tyr为内标,血浆样品经甲醇沉淀蛋白后,上清液用N2吹干,残渣用乙腈-0.05%磷酸(20∶80)复溶后,以乙腈-0.05%磷酸水为流动相梯度洗脱,用Agilent ZORBAXS
To support the pharmacokinetics study of maxingshigan decoction in the rat, a facile HPLC-MS/MS method was developed and validated for the simultaneous determination of ephedrine, pseudoephedrine and
Dioscoreapanthaicais a traditional Chinese medicinal herb which has been used to treat cardiovascular disease, gastropathy and hypertension.Steroidal saponins(SS) are the main active ingredients of th
目的:建立对照提取物法测定健脾丸中4中成分的含量测定方法,并对含量测定结果进行不确定度分析.方法:通过HPLC法测定4种黄酮类成分的含量,建立数学模型计算各变量的不确定度,由此计算合成不确定度及扩展不确定度.结果:采用本方法测定健脾丸中芸香柚皮苷、柚皮苷、橙皮苷含量的扩展不确定度分别为W×0.92%、W×0.97%、W×1.22%、W×1.06%.结论:该方法可作为HPLC测定健脾丸含量不确定度分